These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 3926326

  • 21. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC, Weitzen ML, Kahle R, Granger GA, Bonavida B.
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [Abstract] [Full Text] [Related]

  • 22. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
    Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E.
    J Exp Med; 1992 Mar 01; 175(3):789-96. PubMed ID: 1346797
    [Abstract] [Full Text] [Related]

  • 23. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
    Scott-Algara D, Vuillier F, Cayota A, Dighiero G.
    Clin Exp Immunol; 1992 Nov 01; 90(2):181-7. PubMed ID: 1424272
    [Abstract] [Full Text] [Related]

  • 24. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers.
    Nair MP, Laing TJ, Schwartz SA.
    Clin Immunol Immunopathol; 1986 Jan 01; 38(1):68-78. PubMed ID: 3484438
    [Abstract] [Full Text] [Related]

  • 25. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ, Bochan MR, Montel A, Padilla LM, Brahmi Z.
    Cell Immunol; 1994 Dec 01; 159(2):246-61. PubMed ID: 7994757
    [Abstract] [Full Text] [Related]

  • 26. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N.
    J Immunol; 1985 Jul 01; 135(1):180-4. PubMed ID: 3923100
    [Abstract] [Full Text] [Related]

  • 27. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J, Menezes J, Mercier G, Lamoureux G, Oth D.
    Viral Immunol; 1990 Jul 01; 3(1):55-65. PubMed ID: 2153385
    [Abstract] [Full Text] [Related]

  • 28. The regulation and biological activity of interleukin 12.
    Lee SM, Suen Y, Qian J, Knoppel E, Cairo MS.
    Leuk Lymphoma; 1998 May 01; 29(5-6):427-38. PubMed ID: 9643557
    [Abstract] [Full Text] [Related]

  • 29. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD.
    Scand J Immunol; 1986 Jul 01; 24(1):93-108. PubMed ID: 3088722
    [Abstract] [Full Text] [Related]

  • 30. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
    Uchida A, Yanagawa E, Kokoschka EM, Micksche M, Koren HS.
    Br J Cancer; 1984 Oct 01; 50(4):483-92. PubMed ID: 6237664
    [Abstract] [Full Text] [Related]

  • 31. Influence of lectin-free interleukin-2 on natural and antibody-dependent cellular cytotoxicity.
    Kimber I, Bakács T, Roberts K, Moore M.
    J Clin Lab Immunol; 1984 Oct 01; 15(2):77-84. PubMed ID: 6440995
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12.
    Nguyen QH, Roberts RL, Ank BJ, Lin SJ, Lau CK, Stiehm ER.
    Clin Diagn Lab Immunol; 1998 Jan 01; 5(1):98-104. PubMed ID: 9455889
    [Abstract] [Full Text] [Related]

  • 33. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A, Ferm MT, Ng J, Reynolds CW, Ortaldo JR.
    J Immunol; 1988 Jun 15; 140(12):4397-402. PubMed ID: 3131433
    [Abstract] [Full Text] [Related]

  • 34. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 35. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
    Hirai N, Hill NO, Motoo Y, Osther K.
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug 01; 93(4):153-9. PubMed ID: 4050442
    [Abstract] [Full Text] [Related]

  • 36. Enhanced interferon production and lymphokine-activated cytotoxicity of human placental cells.
    Chin TW, Ank BJ, Strom SR, Stiehm ER.
    Cell Immunol; 1988 Apr 15; 113(1):1-9. PubMed ID: 3130192
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.
    J Immunol; 2001 Feb 01; 166(3):1590-600. PubMed ID: 11160200
    [Abstract] [Full Text] [Related]

  • 38. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH, Roberts RL, Ank BJ, Lin SJ, Thomas EK, Stiehm ER.
    Cell Immunol; 1998 May 01; 185(2):83-92. PubMed ID: 9636686
    [Abstract] [Full Text] [Related]

  • 39. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR, Winkler-Pickett R, Morgan AC, Woodhouse C, Kantor R, Reynolds CW.
    J Immunol; 1987 Nov 01; 139(9):3159-65. PubMed ID: 3668253
    [Abstract] [Full Text] [Related]

  • 40. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP, Schwartz SA.
    J Immunol; 1984 Jun 01; 132(6):2876-82. PubMed ID: 6202765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.